Swiss National Bank Decreases Position in Xylem Inc. (NYSE:XYL)

Swiss National Bank cut its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 2.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 753,092 shares of the industrial products company's stock after selling 16,800 shares during the quarter. Swiss National Bank owned about 0.31% of Xylem worth $86,124,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in XYL. Invesco Ltd. raised its position in shares of Xylem by 35.1% in the 3rd quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company's stock worth $380,762,000 after buying an additional 1,086,102 shares during the period. American Century Companies Inc. raised its holdings in shares of Xylem by 66.8% in the 3rd quarter. American Century Companies Inc. now owns 2,159,710 shares of the industrial products company's stock worth $196,598,000 after purchasing an additional 864,711 shares during the period. AEGON ASSET MANAGEMENT UK Plc acquired a new position in shares of Xylem in the 4th quarter valued at about $74,297,000. Morgan Stanley grew its holdings in shares of Xylem by 11.5% during the 3rd quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company's stock worth $412,267,000 after purchasing an additional 466,911 shares during the period. Finally, Robeco Schweiz AG increased its position in Xylem by 32.8% during the 3rd quarter. Robeco Schweiz AG now owns 1,528,429 shares of the industrial products company's stock worth $139,133,000 after purchasing an additional 377,748 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Up 0.9 %

Shares of NYSE:XYL traded up $1.22 during trading on Friday, hitting $137.21. The company's stock had a trading volume of 1,418,175 shares, compared to its average volume of 1,226,487. The company has a market capitalization of $33.26 billion, a PE ratio of 48.83, a PEG ratio of 2.69 and a beta of 1.08. Xylem Inc. has a fifty-two week low of $87.59 and a fifty-two week high of $138.46. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.30 and a current ratio of 1.67. The stock's 50-day moving average price is $128.64 and its two-hundred day moving average price is $115.54.

Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.06. The company had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2 billion. Xylem had a return on equity of 8.95% and a net margin of 8.34%. Xylem's quarterly revenue was up 40.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.72 EPS. As a group, sell-side analysts expect that Xylem Inc. will post 4.24 EPS for the current year.

Xylem Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, February 20th. This represents a $1.44 dividend on an annualized basis and a yield of 1.05%. This is a boost from Xylem's previous quarterly dividend of $0.33. Xylem's dividend payout ratio (DPR) is currently 51.25%.

Insider Activity at Xylem

In other news, SVP Franz Cerwinka sold 2,408 shares of the company's stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company's stock, valued at approximately $360,682.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the company's stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now owns 11,750 shares of the company's stock, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. Insiders own 0.27% of the company's stock.

Analyst Upgrades and Downgrades

XYL has been the topic of several research reports. Oppenheimer raised their price target on shares of Xylem from $142.00 to $147.00 and gave the company an "outperform" rating in a report on Friday. Citigroup lifted their target price on shares of Xylem from $126.00 to $139.00 and gave the company a "neutral" rating in a report on Monday, April 8th. Robert W. Baird upped their price target on shares of Xylem from $151.00 to $155.00 and gave the stock an "outperform" rating in a research report on Friday. Royal Bank of Canada raised their price objective on Xylem from $157.00 to $162.00 and gave the company an "outperform" rating in a research report on Friday. Finally, BNP Paribas assumed coverage on Xylem in a research report on Tuesday, March 12th. They issued an "outperform" rating and a $150.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $140.70.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.